ESOPMay 15, 2026, 04:06 PM
4D Molecular Therapeutics Grants 141,100 RSUs to 14 New Employees
AI Summary
4D Molecular Therapeutics announced that its compensation committee granted 141,100 Restricted Stock Units (RSUs) to 14 new non-executive employees on May 12, 2026. These RSUs were issued under the Company's 2025 Employment Inducement Award Plan, as amended, in accordance with Nasdaq Global Market Rule 5635(c)(4) to attract new talent.
Key Highlights
- 4D Molecular Therapeutics granted 141,100 Restricted Stock Units (RSUs).
- The RSUs were granted to 14 new non-executive employees.
- The grants were made on May 12, 2026.
- Awards were pursuant to the Company's 2025 Employment Inducement Award Plan.
- The grants were made under Rule 5635(c)(4) of The Nasdaq Global Market.
Price Impact
More from FDMT